Vicarious Surgical posts Q3 net loss of $11.1 million

Reuters11-13
Vicarious Surgical posts Q3 net loss of $11.1 million

Vicarious Surgical Inc. reported a GAAP net loss of $11.1 million, or $1.86 per share, for the third quarter of 2025, compared to a GAAP net loss of $17.1 million, or $2.90 per share, in the third quarter of 2024. The non-GAAP adjusted net loss for the third quarter of 2025 was $11.3 million, or $1.91 per share, down from $17.0 million, or $2.87 per share, a year earlier. Total operating expenses decreased by 35% year-over-year to $11.5 million, while sales and marketing expenses declined by 71% to $0.4 million. The company reported a cash and investments balance of $13.4 million as of September 30, 2025, with a third quarter cash burn rate of $10.5 million. Vicarious Surgical expects full year 2025 cash burn of approximately $50.0 million and raised $5.9 million in gross proceeds from a registered direct offering in October. The company stated it has made progress toward design freeze and has implemented a plan to reduce its burn rate while maintaining development timelines.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicarious Surgical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251112785714) on November 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment